Janus Henderson Global Life Sciences Fund Class T (JAGLX)

Fund Assets	6.03B
Expense Ratio	0.92%
Min. Investment	$2,500
Turnover	30.00%
Dividend (ttm)	0.31
Dividend Yield	0.36%
Dividend Growth	101.63%
Payout Frequency	Annual
Ex-Dividend Date	Dec 5, 2025

Previous Close	85.96
YTD Return	6.28%
1-Year Return	21.56%
5-Year Return	55.37%
52-Week Low	73.33
52-Week High	93.51
Beta (5Y)	0.59
Holdings	98
Inception Date	Dec 31, 1998

About JAGLX

Janus Henderson Global Life Sciences Fund Class T is a mutual fund focused on the health sector, aiming to provide long-term capital growth. It invests primarily in companies with a life science orientation, seeking those that address unmet medical needs or enhance healthcare efficiency. The fund maintains a balanced portfolio across various sub-sectors, including biotechnology, healthcare services, medical devices, and pharmaceuticals. With a diversified approach across market capitalizations and geographies, it leverages the expertise of seasoned specialists to navigate the complex healthcare sector. By emphasizing growth potential and innovation, this fund plays a significant role in the financial market by capitalizing on advancements in healthcare technology and services.

• Fund Family: Janus Henderson
• Category: Health
• Performance Rating: High
• Risk Rating: Average
• Stock Exchange: Nasdaq
• Ticker Symbol: JAGLX
• Share Class: Class T
• Index: MSCI World/Health Care NR

Performance

JAGLX had a total return of 21.56% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.51%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
JFNNX	Class N	0.68%
JFNIX	Class I	0.78%
JNGLX	Class D	0.81%
JFNAX	Class A	1.00%

Top 10 Holdings

42.22% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	9.05%
Johnson & Johnson	JNJ	7.48%
AbbVie Inc.	ABBV	4.63%
UnitedHealth Group Incorporated	UNH	4.33%
AstraZeneca PLC	AZN	3.50%
Thermo Fisher Scientific Inc.	TMO	2.92%
Novartis AG ADR	NVSN.MX	2.78%
Roche Holding AG	ROP	2.63%
argenx SE	ARGX	2.55%
Abbott Laboratories	ABT	2.36%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 5, 2025	$3.64134	Dec 5, 2025
Dec 6, 2024	$3.86839	Dec 6, 2024
Dec 7, 2023	$2.89991	Dec 7, 2023
Dec 20, 2022	$0.09366	Dec 20, 2022
Dec 20, 2021	$6.73381	Dec 20, 2021
Dec 17, 2020	$5.50316	Dec 17, 2020

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Oct 7, 2026

Data Sources Report a data error